FDA information regarding COVID-19
March 18, 2020
FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Pandemic
Guidance for Industry, Investigators, and Institutional Review Boards
March 27, 2020
FDA Updates Guidance with an Appendix Adding Questions and Answers on Conduct of Clinical Trials of Medical Products During COVID-19 Pandemic
Guidance for Industry, Investigators, and Institutional Review Boards
April 7, 2020
Visit the FDA Coronavirus (COVID-19) | Drugs page to learn more about efforts led by The Center for Drug Evaluation and Research (CDER), and for contact information.
April 13, 2020
Visit FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Pandemic Guidance for Industry, Investigators, and Institutional Review Boards
April 17, 2020
FDA Updates Question-and-Answer Appendix in Guidance on Conduct of Clinical Trials of Medical Products During the COVID-19 Public Health Emergency
Overview
Content Tools
ThemeBuilder